Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Drug firm doubles cannabis trials

Reuters

Thursday 11 Apr 2002

---
LONDON (Reuters) - Drug firm GW Pharmaceuticals (LSE: GWP.L, news), which
is developing cannabis-based prescription drugs, says it is expanding its
clinical trials programme to cover four new potential areas of treatment.

The company said on Thursday the new Phase III trials would examine the
effectiveness of cannabis-based medicines in treating pain and sleep in
patients with spinal injury, Multiple Sclerosis and a variety of
neuropathic problems.

The new Phase III trials take the total number being conducted by GW Pharma
to seven.

Drugs have to pass Phase III trials before coming to market.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!